Added to YB: 2024-03-08
Pitch date: 2024-03-07
BHC [neutral]
Bausch Health Companies Inc.
-26.1%
current return
Author Info
Company Info
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally.
Market Cap
$2.6B
Pitch Price
$9.35
Price Target
12.99 (+88%)
Dividend
N/A
EV/EBITDA
7.35
P/E
26.95
EV/Sales
2.39
Sector
Pharmaceuticals
Category
value
Fundamentals: Bausch's Terrible Balance Sheet
BHC: Trades at 2.4x 2024 EPS despite double-digit growth, but heavy debt load (~6x market cap) and patent cliff risk justify low multiple. Credit markets imply 40%+ bankruptcy risk by 2027. $4.9B BLCO stake spin-off could drive 40% upside but currently paused due to lawsuit.
Read full article (9 min)